Jaye Viner, M.D., has been appointed chief medical officer and executive vice president of Curis, Inc. Dr. Viner will be responsible for the leadership of Curis’ clinical development strategy and development efforts for its pipeline of proprietary drug candidates. Also, Tania Chander, Pharm.D., has been named vice president of product development, responsible for project leadership throughout the product development process.   Dr. Viner previously served as a medical director at Millennium...